1. Introduction {#sec1}
===============

*Pasteurella multocida* (*P. multocida*) empyema is a rare clinical entity. We describe a patient with *P. multocida* empyema, as well as analyze all the available reports previously published in the medical literature. We describe the clinical and pleural fluid characteristics of these cases.

2. Methods {#sec2}
==========

We performed a PubMed search for *P. multocida* empyema using keywords '*Pasteurella multocida*', 'empyema' and 'pleural effusion'. We identified 20 case reports in addition to our own and present their pleural fluid findings in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}. The mean and standard deviation (for quantitative variables) are also presented. Findings of pleural fluid analysis are reported in conventional units wherever possible.

2.1. Case report {#sec2.1}
----------------

A 75-year-old man was hospitalized for 3 weeks of progressive shortness of breath. He had a history of an ischemic cardiomyopathy and valvular heart disease, and had undergone coronary artery bypass grafting, aortic and mitral valve repair. He also had hypertension, atrial fibrillation and had not been anticoagulated because of gastrointestinal bleeding. He had end stage renal disease presumed secondary to hypertension and had required renal replacement therapy for the last 3 years. He was a former smoker of 70 pack-years and had a pet dog.

Physical examination at the time of transfer to medical ICU showed that he was in mild respiratory distress with temperature 38.2 C, respiratory rate of 18/min, blood pressure 95/54 mmHg, irregularly irregular pulse 101/min and oxygen saturation 94% on 3L/min supplemental oxygen. Lung auscultation revealed decreased breath sounds with dullness to percussion at the posterior left base.

Laboratory data included: white blood cell count 16,100 cells/μl, hemoglobin 9.4 mg/dl, platelet count 152,000/μl. A chest radiograph showed a large left pleural effusion. Bedside ultrasonography revealed a homogeneously echogenic pleural effusion. A small-bore chest tube was introduced under ultrasound guidance. Purulent fluid was aspirated.

Pleural fluid analysis showed: pH 7.04, glucose \<5 mg/dl, protein 3.3 gm/dl, LDH 1535 U/L, WBC 45,160/μl with 99% neutrophils, RBC 12,000/cmm. Pleural fluid Gram stain was negative. Piperacillin/tazobactam and linezolid were initiated.

*P. multocida* was detected on pleural fluid culture within 24 hours that was resistant to ampicillin but sensitive to amoxicillin/clavulanate. Linezolid was discontinued. Intra-pleural tPA and DNase were instilled through the chest tube that resulted in evacuation of the space (total fluid drained = 1.6L) with a residual pneumothorax suggestive of lung entrapment (trapped lung physiology). His dyspnea improved and he was transferred to the general medical ward. His fever resolved; oxygenation and leukocytosis continued to improve. However, the patient developed massive gastrointestinal bleeding resulting in cardio-respiratory arrest leading to death.

3. Discussion {#sec3}
=============

We report the case of an elderly man with *P. multocida* empyema. He received timely and aggressive antibiotic therapy and complete drainage of the pleural space. Although therapy resulted in clinical improvement; he died from gastrointestinal bleeding and cardiac problems.

*P. multocida* is a gram negative encapsulated non-motile coccobacillus. It forms part of the normal flora in the oropharynx and nasopharynx but can also be a pathogen [@bib21]. Animal exposure; usually from the scratch, bite or lick of a domestic cat or dog, is an important risk factor and is present in most cases of Pasteurella infection [@bib21], [@bib22].

Infection due to *P. multocida* is usually limited to the skin and soft tissue with regional complications [@bib23]. *P. multocida* infection of the respiratory tract is uncommon, as is pleural infection that has been described in isolated case reports [@bib22]. We identified 21 published reports, including our own, of *P. multocida* infected pleural effusions. In [Table 1](#tbl1){ref-type="table"}; we describe the clinical characteristics and outcome of these cases. [Table 1](#tbl1){ref-type="table"} suggests that most patients with *P. multocida* pleural infection have underlying cardiopulmonary disease and/or are immunocompromised (12/21, 57%) and majority of patients had exposure to animals (15/21, 71%). Pleural drainage is often required (13/21, 62%) and the condition carries a high mortality (9/20, 45%).

[Table 2](#tbl2){ref-type="table"} displays the available pleural fluid characteristics of these patients. The effusions are predominantly complicated parapneumonic effusions with 87% (13/15) described as purulent, and the following pleural fluid findings: very low pH (mean 6.8), high protein (mean 4.8 g/dl), high LDH (mean 1911 U/L) and a very low glucose concentration (mean 28.6 mg/dl). The mean pleural WBC count in the reported cases was 17,776 and there was a predominance of polymorphonuclear leukocytes in the large majority of the cases (mean 86%, 10/11 cases \> 50%). Pleural fluid culture was positive in 90% of reported cases (18/20).

Our case report and literature review highlight that *P. multocida* may cause significant pleural disease. Pleural fluid findings typically reveal a complicated parapneumonic pleural effusion that often requires drainage. Pleural infection with *P. multocida* is often fatal, which may reflect the severity of infection or the moribund state of the patients who develop this infection.
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###### 

Clinical characteristics and outcomes.

  Reference number   Age (years)   Sex            Side of pleural effusion             Significant comorbidities         Chest tube              Outcome
  ------------------ ------------- -------------- ------------------------------------ --------------------------------- ----------------------- -----------
  [@bib1]            63            M              Left                                 None known                        Yes                     Death
  [@bib2]            8             F              Right                                Noonan syndrome                   Yes                     Survived
  [@bib3]            57            F              Bilateral                            CHF                               Yes                     Survived
  [@bib4]            64            F              Left                                 Liver cirrhosis                   Yes                     Survived
  [@bib5]            86            F              Left                                 None known                        No                      Survived
  [@bib6]            69            F              Right                                Liver cirrhosis                   Yes                     Death
  [@bib7]            54            F              Left                                 COPD                              Yes                     Survived
  [@bib8]            60            M              Right                                None known                        No                      Death
  [@bib9]            57            F              Left                                 Liver cirrhosis, asplenia         Yes                     Death
  [@bib10]           85            F              Bilateral                            None known                        Yes                     Survived
  [@bib11]           65            F              Right                                RA on steroids and methotrexate   Yes                     Survived
  [@bib12]           88            M              Right                                None known                        Yes                     Death
  [@bib13]           90            M              Right                                None known                        No                      Survived
  [@bib14]           76            M              Right                                Prostate CA, PVD, smoking         Yes                     Survived
  [@bib15]           76            F              Right                                None known                        No                      Death
  [@bib16]           77            M              Right                                None known                        No                      Survived
  [@bib17]           51            M              Right                                Bronchiectasis and BPF            No                      Survived
  [@bib18]           72            F              Right                                Chronic bronchitis                No                      NR
  [@bib19]           75            M              Bilateral                            None known                        No                      Death
  [@bib20]           67            F              Right                                Liver cirrhosis and CHF           Yes                     Death
  Present Case       75            M              Left                                 ESRD, valvular/coronary disease   Yes                     Death
  Mean               67 (±17.7)    40% M, 60% F   57% Right, 29% Left, 14% Bilateral   57% Present, 43% None known       62% Chest tube placed   45% Death

F = Female, M = Male, CHF = congestive heart failure, COPD = chronic obstructive pulmonary disease, RA = rheumatoid arthritis, CA = cancer, PVD = peripheral vascular disease, BPF = bronchopleural fistula, ESRD = end stage renal disease, NR = not reported.

###### 

Summary of findings of pleural fluid analysis.

  Reference number                         Appearance       pH          Total protein G/DL   LDH (U/L)                              Glucose Mg/DL   WBC[a](#tbl2fna){ref-type="table-fn"}count   PMN %
  ---------------------------------------- ---------------- ----------- -------------------- -------------------------------------- --------------- -------------------------------------------- ---------
  1                                        Purulent         NR          NR                   NR                                     NR              NR                                           NR
  2                                        Chylous          NR          8.8                  NR                                     NR              8014                                         89
  3                                        Purulent         NR          12.6                 1590                                   3               10,500                                       98
  4                                        Serosanguinous   NR          3.2                  NR                                     100             19,150                                       91
  5                                        Purulent         6.53        5.6                  403                                    4               7000                                         96
  6                                        Purulent         6.69        3                    NR                                     5.4             10,500                                       98
  7                                        NR               6.9         NR                   NR                                     12              5140                                         NR
  8                                        NR               NR          NR                   NR                                     NR              NR                                           NR
  9                                        Purulent         NR          NR                   NR                                     NR              NR                                           NR
  10                                       NR               6.8         4.9                  NR[b](#tbl2fnb){ref-type="table-fn"}   1.44            160                                          60
  11                                       NR               7.23        4.3                  4209                                   44              13,900                                       43
  12                                       Purulent         NR          4.2                  NR                                     69              74,888                                       84
  13                                       Purulent         NR          0.004                1676                                   59              17,100                                       95
  14                                       Purulent         6.6         3.4                  2052                                   11.7            1800                                         88
  15                                       Purulent         NR          NR                   NR                                     NR              NR                                           NR
  16                                       Purulent         NR          NR                   NR                                     NR              NR                                           NR
  17                                       Purulent         NR          NR                   NR                                     NR              NR                                           NR
  18                                       NR               NR          NR                   NR                                     NR              NR                                           NR
  19                                       NR               NR          NR                   NR                                     NR              NR                                           NR
  20                                       Purulent         NR          NR                   NR                                     NR              NR                                           NR
  Present Case                             Purulent         7.04        3.3                  1535                                   \<5             45,160                                       99
  Mean[c](#tbl2fnc){ref-type="table-fn"}   87% Purulent     6.8 ± 0.2   4.8 ± 3.3            1911 ± 1255                            29 ± 34         17,776 ± 21,472                              86 ± 18

LDH: lactate dehydrogenase; PMN = polymorphonuclear leukocytes; WBC: white blood cell; NR = not reported.

Pleural fluid WBC count reported in several different units among these references; we therefore displayed the pleural WBC counts in units consistent with the peripheral WBC count in each reference.

LDH was elevated but could not be converted to conventional units.

±standard deviation, if applicable.
